HBW
Hazlett, Burt & Watson’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
65
| – | – | ﹤0.01% | 766 |
|
|
2025
Q1 | $1K | Hold |
65
| – | – | ﹤0.01% | 764 |
|
|
2024
Q4 | $2K | Hold |
65
| – | – | ﹤0.01% | 707 |
|
|
2024
Q3 | $1K | Hold |
65
| – | – | ﹤0.01% | 706 |
|
|
2024
Q2 | $1K | Hold |
65
| – | – | ﹤0.01% | 687 |
|
|
2024
Q1 | $1K | Hold |
65
| – | – | ﹤0.01% | 686 |
|
|
2023
Q4 | $1K | Hold |
65
| – | – | ﹤0.01% | 661 |
|
|
2023
Q3 | $1K | Hold |
65
| – | – | ﹤0.01% | 688 |
|
|
2023
Q2 | $3K | Hold |
65
| – | – | ﹤0.01% | 599 |
|
|
2023
Q1 | $4K | Hold |
65
| – | – | ﹤0.01% | 539 |
|
|
2022
Q4 | $5K | Hold |
65
| – | – | ﹤0.01% | 522 |
|
|
2022
Q3 | $5K | Hold |
65
| – | – | ﹤0.01% | 513 |
|
|
2022
Q2 | $5K | Hold |
65
| – | – | ﹤0.01% | 512 |
|
|
2022
Q1 | $5K | Buy |
+65
| New | +$5K | ﹤0.01% | 521 |
|